Description
The Practicing Oncologists Working Group is pleased to present a new series of Spotlight articles featuring highlights from the ESMO 2021 Congress.
Watch the presentations and make sure you keep up to date on the key practice changing outcomes from this year's annual meeting.
Produced by the Practising Oncologists Working Group
Featured abstract
LBA20 - FOLFOXIRI plus bevacizumab (bev) plus atezolizumab (atezo) versus FOLFOXIRI plus bev as first-line treatment of unresectable metastatic colorectal cancer (mCRC) patients: Results of the phase II randomized AtezoTRIBE study by GONO
Presenter: Chiara Cremolini - Session: Proffered Paper session - Gastrointestinal tumours, colorectal 1
Abstract, slides and webcast
Last update:
09 Dec 2021
